Truist Securities Reiterates Buy Rating on Kymera Therapeutics (KYMR)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/1/2026

1. SPY
2. MDT
3. SPGI
4. USO
5. AAPL
6. DELL
7. NIO
8. ENOV
9. AON
10. A

Go back to Truist Securities Reiterates Buy Rating on Kymera Therapeutics (KYMR)
(NASDAQ: KYMR) Delayed: 119.05 +0.24 (0.20%)
Previous Close $118.81    52 Week High $ 
Open $116.92    52 Week Low $ 
Day High $119.79    P/E N/A 
Day Low $116.28    EPS $ 
Volume 576,626